{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T05:29:30Z","timestamp":1787030970511,"version":"build-2736575974"},"reference-count":35,"publisher":"Scientific Scholar","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,8]]},"abstract":"\n Background & objectives:<\/jats:title>\n Sickle cell disease (SCD) constitutes frequently inherited haemoglobin disorders and poses a significant health burden in India. Hydroxyurea (HU), the most commonly used drug, has shown promising results in the clinical management of SCD. The present systematic review was undertaken to assess the efficacy and toxicity of HU in Indian sickle cell patients.<\/jats:p>\n <\/jats:sec>\n \n Methods:<\/jats:title>\n A systematic review of studies on HU therapy was conducted to identify the application of HU and its outcome(s) across India. PubMed, Scopus and Cochrane Library was used as data sources for various studies on the efficacy and toxicity of HU therapy for treatment for SCD in India published between January 2001 and October 2021. Two authors independently extracted the data on study design, patient characteristics and therapeutic outcomes of HU in order to determine the study quality of the present review.<\/jats:p>\n <\/jats:sec>\n \n Results:<\/jats:title>\n Overall, 14 studies were included for a systematic analysis. Of these 11 were prospective, two cross-sectional and one double-blind randomized controlled trial. Low-dose HU (10 mg\/kg\/day) was found to reduce the rates of vaso-occlusive crisis and hospitalization as well as decreased the requirement of blood transfusion in SCD patients. The foetal haemoglobin (HbF) level was recorded in 13 (80%) studies all of whom reported an elevation in the HbF levels, with a mean increase in per cent HbF from 15.8 to 21.4 per cent across studies. The common adverse events were reversible, mild-to-moderate cytopenia and anaemia.<\/jats:p>\n <\/jats:sec>\n \n Interpretation & conclusions:<\/jats:title>\n The findings of the present review suggest that there is still insufficient information presently to determine the long-term or major adverse effects on organ damage, fertility as well as pregnancy on the use of HU therapy for SCD. Long-term multi-centric studies are thus required to address these problems.<\/jats:p>\n <\/jats:sec>","DOI":"10.4103\/ijmr.ijmr_3447_21","type":"journal-article","created":{"date-parts":[[2023,1,9]],"date-time":"2023-01-09T02:52:41Z","timestamp":1673232761000},"page":"299-311","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":10,"title":["A systematic review on hydroxyurea therapy for sickle cell disease in India"],"prefix":"10.25259","volume":"156","author":[{"given":"Apoorva","family":"Pandey","sequence":"first","affiliation":[{"name":"Division of Epidemiological & Communicable Diseases, Indian Council of Medical Research, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harpreet","family":"Kaur","sequence":"additional","affiliation":[{"name":"Division of Epidemiological & Communicable Diseases, Indian Council of Medical Research, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sapan","family":"Borah","sequence":"additional","affiliation":[{"name":"Department of Haematogenetics, ICMR-National Institute of Immunohaematology, Mumbai, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naveen","family":"Khargekar","sequence":"additional","affiliation":[{"name":"Department of Haematogenetics, ICMR-National Institute of Immunohaematology, Mumbai, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijay Kumar","family":"Karra","sequence":"additional","affiliation":[{"name":"Division of Epidemiological & Communicable Diseases, Indian Council of Medical Research, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tulsi","family":"Adhikari","sequence":"additional","affiliation":[{"name":"ICMR-National Institute of Medical Statistics, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dipty","family":"Jain","sequence":"additional","affiliation":[{"name":"Department of Paediatrics, Government Medical College, Nagpur, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manisha","family":"Madkaikar","sequence":"additional","affiliation":[{"name":"Department of Paediatric Immunology & Leukocyte Immunology, ICMR-National Institute of Immunohaematology, Mumbai, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10894","published-online":{"date-parts":[[2023,1,5]]},"reference":[{"key":"R1-20241212","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/nyas.12988","article-title":"Understanding \u03b1-globin gene regulation and implications for the treatment of \u03b2-thalassemia","volume":"1368","author":"Mettananda","year":"2016","journal-title":"Ann N Y Acad Sci"},{"key":"R2-20241212","doi-asserted-by":"crossref","first-page":"e1001484","DOI":"10.1371\/journal.pmed.1001484","article-title":"Global burden of sickle cell anaemia in children under five, 2010-2050:Modelling based on demographics, excess mortality, and interventions","volume":"10","author":"Piel","year":"2013","journal-title":"PLoS Med"},{"key":"R3-20241212","doi-asserted-by":"crossref","first-page":"e0147081","DOI":"10.1371\/journal.pone.0147081","article-title":"Neonatal screening and the clinical outcome in children with sickle cell disease in central India","volume":"11","author":"Upadhye","year":"2016","journal-title":"PLoS One"},{"key":"R4-20241212","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1007\/s13312-012-0217-z","article-title":"Sickle cell anemia from central India:A retrospective analysis","volume":"49","author":"Jain","year":"2012","journal-title":"Indian Pediatr"},{"key":"R5-20241212","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.3389\/fmed.2021.745189","article-title":"Sickle cell disease:Thoughts for India from the Jamaican cohort study","volume":"8","author":"Serjeant","year":"2021","journal-title":"Front Med"},{"key":"R6-20241212","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/MOH.0000000000000029","article-title":"Sickle cell disease in India","volume":"21","author":"Colah","year":"2014","journal-title":"Curr Opin Hematol"},{"key":"R7-20241212","doi-asserted-by":"crossref","first-page":"509","DOI":"10.4103\/0971-5916.159492","article-title":"Sickle cell disease in tribal populations in India","volume":"141","author":"Colah","year":"2015","journal-title":"Indian J Med Res"},{"key":"R8-20241212","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/00062752-200203000-00006","article-title":"Sickle cell disease in India","volume":"9","author":"Mohanty","year":"2002","journal-title":"Curr Opin Hematol"},{"key":"R9-20241212","doi-asserted-by":"crossref","first-page":"154","DOI":"10.4103\/0971-6866.73410","article-title":"Clinical, hematologic and molecular variability of sickle cell-\u03b2thalassemia in western India","volume":"16","author":"Mukherjee","year":"2010","journal-title":"Indian J Hum Genet"},{"key":"R10-20241212","first-page":"239","article-title":"Geographical survey of \u03b2S-globin gene haplotypes:Evidence for an independent Asian origin of the sickle-cell mutation","volume":"39","author":"Kulozik","year":"1986","journal-title":"Am J Hum Genet"},{"key":"R11-20241212","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1002\/(SICI)1096-8652(199706)55:2<104::AID-AJH9>3.0.CO;2-X","article-title":"Effect of alpha-thalassemia on sickle-cell anemia linked to the Arab-Indian haplotype in India","volume":"55","author":"Mukherjee","year":"1997","journal-title":"Am J Hematol"},{"key":"R12-20241212","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/jcla.21652","article-title":"Phenotypic effect of \u03b1-globin gene numbers on Indian sickle \u03b2-thalassemia patients","volume":"28","author":"Pandey","year":"2014","journal-title":"J Clin Lab Anal"},{"key":"R13-20241212","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1127\/anthranz\/60\/2002\/169","article-title":"Sickle cell disease among tribes of Andhra Pradesh and Orissa, India","volume":"60","author":"Babu","year":"2002","journal-title":"Anthropol Anz"},{"key":"R14-20241212","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2174\/187152512799201190","article-title":"Community expansion and gene geography of sickle cell trait and G6PD deficiency, and natural selection against malaria:Experience from tribal land of India","volume":"10","author":"Balgir","year":"2012","journal-title":"Cardiovasc Hematol Agents Med Chem"},{"key":"R15-20241212","doi-asserted-by":"crossref","first-page":"663","DOI":"10.4103\/0971-5916.159582","article-title":"Burden &pattern of illnesses among the tribal communities in central India:A report from a community health programme","volume":"141","author":"Jain","year":"2015","journal-title":"Indian J Med Res"},{"key":"R16-20241212","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.bjhh.2015.03.013","article-title":"Socioeconomic and demographic characteristics of sickle cell disease patients from a low-income region of northeastern Brazil","volume":"37","author":"Fernandes","year":"2015","journal-title":"Rev Bras Hematol Hemoter"},{"key":"R18-20241212","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.18203\/2394-6040.ijcmph20161399","article-title":"Initial outcomes of a comprehensive care model for sickle cell disease among a tribal population in rural western India","volume":"3","author":"Desai","year":"2016","journal-title":"Int J Community Med Public Health"},{"key":"R19-20241212","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1136\/jech.52.6.377","article-title":"The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions","volume":"52","author":"Downs","year":"1998","journal-title":"J Epidemiol Community Health"},{"key":"R20-20241212","doi-asserted-by":"crossref","first-page":"323","DOI":"10.3109\/03630269.2012.697948","article-title":"Low fixed-dose hydroxyurea in severely affected Indian children with sickle cell disease","volume":"36","author":"Jain","year":"2012","journal-title":"Hemoglobin"},{"key":"R21-20241212","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.bcmd.2008.08.003","article-title":"Hydroxyurea in sickle cell disease \u2013A study of clinico-pharmacological efficacy in the Indian haplotype","volume":"42","author":"Italia","year":"2009","journal-title":"Blood Cells Mol Dis"},{"key":"R22-20241212","doi-asserted-by":"crossref","first-page":"29","DOI":"10.32677\/IJCH.2020.v07.i01.008","article-title":"Short-term safety and beneficial effects of hydroxyurea therapy in children with sickle cell disease","volume":"7","author":"Somkuwar","year":"2020","journal-title":"Indian J Child Health"},{"key":"R23-20241212","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1007\/s13312-013-0264-0","article-title":"Efficacy of fixed low dose hydroxyurea in Indian children with sickle cell anemia:A single centre experience","volume":"50","author":"Jain","year":"2013","journal-title":"Indian Pediatr"},{"key":"R24-20241212","first-page":"EC19","article-title":"Variability of iron load in patients of sickle cell anaemia (HbSS):A study from Eastern India","volume":"11","author":"Mohanty","year":"2017","journal-title":"J Clin Diagn Res"},{"key":"R25-20241212","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1002\/pbc.25004","article-title":"The effect of hydroxyurea on compound heterozygotes for sickle cell-hemoglobin D-Punjab \u2013A single centre experience in eastern India","volume":"61","author":"Patel","year":"2014","journal-title":"Pediatr Blood Cancer"},{"key":"R26-20241212","doi-asserted-by":"crossref","first-page":"409","DOI":"10.3109\/03630269.2012.709897","article-title":"Low dose hydroxyurea is effective in reducing the incidence of painful crisis and frequency of blood transfusion in sickle cell anemia patients from eastern India","volume":"36","author":"Patel","year":"2012","journal-title":"Hemoglobin"},{"key":"R27-20241212","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s12288-015-0542-1","article-title":"Hydroxyurea in sickle cell disease:Our experience in Western India","volume":"32","author":"Deshpande","year":"2016","journal-title":"Indian J Hematol Blood Transfus"},{"key":"R28-20241212","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1002\/pbc.25391","article-title":"Low and fixed dose of hydroxyurea is effective and safe in patients with HbS\u03b2(+) thalassemia with IVS1-5(G?C) mutation","volume":"62","author":"Dehury","year":"2015","journal-title":"Pediatr Blood Cancer"},{"key":"R29-20241212","first-page":"494","article-title":"Effect of hydroxyurea on clinical and haematological profile of children with sickle cell anaemia","volume":"7","author":"Barma","year":"2020","journal-title":"Int J Res Rev"},{"key":"R30-20241212","doi-asserted-by":"crossref","first-page":"32","DOI":"10.4103\/0253-7613.62409","article-title":"Effective control of sickle cell disease with hydroxyurea therapy","volume":"42","author":"Singh","year":"2010","journal-title":"Indian J Pharmacol"},{"key":"R31-20241212","doi-asserted-by":"crossref","first-page":"e140","DOI":"10.1097\/MPH.0000000000000049","article-title":"HbSD-Punjab:Clinical and hematological profile of a rare hemoglobinopathy","volume":"36","author":"Oberoi","year":"2014","journal-title":"J Pediatr Hematol Oncol"},{"key":"R32-20241212","first-page":"22","article-title":"Study of seminal fluid parameters and fertility of male sickle cell disease patients and potential impact of hydroxyurea treatment","volume":"65","author":"Sahoo","year":"2017","journal-title":"J Assoc Physicians India"},{"key":"R33-20241212","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1007\/s12288-017-0869-x","article-title":"Beneficial effect of low fixed dose of hydroxyurea in vaso-occlusive crisis and transfusion requirements in adult HbSS patients:A prospective study in a tertiary care center","volume":"34","author":"Sethy","year":"2018","journal-title":"Indian J Hematol Blood Transfus"},{"key":"R34-20241212","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/MOH.0000000000000422","article-title":"Clinical manifestations of sickle cell disease in India:Misconceptions and reality","volume":"25","author":"Jain","year":"2018","journal-title":"Curr Opin Hematol"},{"key":"R35-20241212","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1177\/0091270009343933","article-title":"Exposure to hydroxyurea during pregnancy in sickle-\u03b2Thalassemia:A report of 2 cases","volume":"50","author":"Italia","year":"2010","journal-title":"J Clin Pharmacol"},{"key":"R36-20241212","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1001\/jama.2014.10517","article-title":"Management of sickle cell disease:Summary of the 2014 evidence-based report by expert panel members","volume":"312","author":"Yawn","year":"2014","journal-title":"JAMA"}],"container-title":["Indian Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.4103\/ijmr.ijmr_3447_21","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T19:05:22Z","timestamp":1751483122000},"score":1,"resource":{"primary":{"URL":"https:\/\/ijmr.org.in\/a-systematic-review-on-hydroxyurea-therapy-for-sickle-cell-disease-in-india\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.4103\/ijmr.ijmr_3447_21","relation":{},"ISSN":["0971-5916","0975-9174"],"issn-type":[{"value":"0971-5916","type":"print"},{"value":"0975-9174","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"2021-12-03","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}}]}}